Table 2.

Comparison of psychotropic drug prescriptions between GUs and PSUs prior to the coronavirus disease 2019 pandemic

	GU, n = 511	PSU, n = 163	p value
Drugs, median (IQR)	7 (5)	7 (4)	0.580
Psychotropic drugs, median (IQR)	1 (1)	2 (1)	< 0.001*
No psychotropic drugs	114 (22.3)	9 (5.5)
1 treatment group	165 (32.3)	30 (18.4)
2 treatment groups	147 (28.8)	62 (38.0)
≥ 3 treatment groups	85 (16.6)	62 (38.0)
Antipsychotics	159 (31.1)	128 (78.5)	< 0.001*
Quetiapine	83 (52.2)	76 (59.4)	0.224
Risperidone	39 (24.5)	37 (28.9)	0.403
Olanzapine	11 (6.9)	16 (12.5)	0.107
Clozapine	6 (3.8)	5 (3.9)	0.954
Aripiprazole	9 (5.7)	1 (0.8)	0.047*
Equivalent risperidone, median (IQR)	1(2)	1.5 (3)	0.040
Equivalent risperidone >2 mg	48 (30.2)	51 (39.8)	0.100
Benzodiazepines	170 (33.3)	47 (28.8)	0.291
Lorazepam	96 (56.5)	25 (53.2)	0.689
Lormetazepam	38 (22.4)	11 (23.4)	0.879
Diazepam	12 (7.1)	4 (8.5)	0.736
Alprazolam	12 (7.1)	2 (4.3)	0.739
Bromazepam	8 (4.7)	0 (0.0)	0.206
Clorazepate	4 (2.4)	3 (6.4)	0.175
Equivalent lorazepam, median (IQR)	1 (1)	1 (1)	0.164
Antidepressants	281 (55.0)	114 (69.9)	< 0.001*
Trazodone	121 (43.1)	55 (48.2)	0.347
SSRIs	113 (40.2)	46 (40.4)	0.980
Mirtazapine	75 (26.7)	27 (23.7)	0.536
SNRIs	51 (18.1)	12 (10.5)	0.061
Vortioxetine	10 (3.6)	2 (1.8)	0.344
Antiepileptic drugs	110 (21.5)	60 (36.8)	< 0.001*
Pregabaline	47 (44.3)	31 (54.4)	0.252
Levetiracetam	25 (23.6)	6 (10.5)	0.043*
Valproic acid	11 (10.4)	8 (14.0)	0.488
Gabapentine	2 (1.9)	7 (12.3)	0.009*
Topiramate	4 (3.8)	4 (7.0)	0.452

Data are presented as n (%) unless otherwise stated

GU geriatric units, IQR interquartile range, PSU psychogeriatric units, SNRIs serotonin-norepinephrine reuptake inhibitor, SSRI selective serotonin reuptake inhibitors, *p < 0.05